Concepedia

Thomas Plitz

TP

Statistics

Publications

11

Citations

1.3K

H-Index

11

Active since

1999

Affiliations

Ono Pharmaceutical (United States)(Current)

Technical University of Munich

Tallinn University of Technology

Merck Serono (Switzerland)

Thomas Plitz is an author at Ono Pharmaceutical (United States) specializing in medicine, autoimmunity, and immunology.

Top concepts

MedicineImmunologyAutoimmunityAutoimmune DiseaseNeurologyCell BiologyInflammationImmunotherapyCell SignalingNeuroimmunology

Publications per year

1999–2021

11

Publications

11

Atacicept in multiple sclerosis (ATAMS): a randomised, placebo-controlled, double-blind, phase 2 trial

Ludwig Kappos, Hans‐Peter Hartung, Mark S. Freedman et al. · The Lancet Neurology · 2014 · 325 citations

Neurological Disorder, Pain Medicine, Medicine +7

Mature Follicular Dendritic Cell Networks Depend on Expression of Lymphotoxin β Receptor by Radioresistant Stromal Cells and of Lymphotoxin β and Tumor Necrosis Factor by B Cells

Robert G. Endres, Marat Alimzhanov, Thomas Plitz et al. · The Journal of Experimental Medicine · 1999 · 313 citations · Full text

Germinal Centers, Lymphocyte Development, Immunology +22

Bis-choline tetrathiomolybdate in patients with Wilson's disease: an open-label, multicentre, phase 2 study

Karl Heinz Weiss, Frederick K. Askari, Anna Członkowska et al. · The Lancet. Gastroenterology & hepatology · 2017 · 162 citations

Translational Medicine, Pharmacology, Bis-choline Tetrathiomolybdate +3

Copper(II)-binding equilibria in human blood

Tiina Kirsipuu, Anna Zadorožnaja, Julia Smirnova et al. · Scientific Reports · 2020 · 125 citations · Full text

IL-18-Binding Protein Expression by Endothelial Cells and Macrophages Is Up-Regulated During Active Crohn’s Disease

Anne Corbaz, Tessa ten Hove, Suzanne Herren et al. · The Journal of Immunology · 2002 · 84 citations

1–5 of 11